Nancy Maureen Hardy MD FACP

Oncology•Baltimore, MD

Associate Professor, Medicine, Greenebaum Cancer Center

Request appointment

22 S Greene StBaltimore, MD 21201
Book by Phone+1(443) 298-2814
Fax+1 410-328-6841

Overview of Dr. Hardy

Dr. Nancy Hardy is an oncologist in Baltimore, MD and is affiliated with University of Maryland Medical Center. She received her medical degree from University of Washington School of Medicine and has been in practice 31 years. She is one of 110 doctors at University of Maryland Medical Center who specialize in Oncology. She has more than 50 publications and over 500 citings.

Education & Training

National Cancer InstituteFellowship, Stem Cell Transplantation and Immunotherapy, 2003 - 2006
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 1999 - 2003
Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 2001
Duke University HospitalFellowship, Hematology and Medical Oncology, 1998 - 1999
Duke University HospitalResidency, Internal Medicine, 1995 - 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 2004 - 2028
WA State Medical License 2010 - 2026
NC State Medical License 1998 - 2022
DC State Medical License 2013 - 2014

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells Start of enrollment: 2010 Dec 10
RECRUITING
PHASE2
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2011 Mar 30
TERMINATED
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
COMPLETED
PHASE1

Publications & Presentations

PubMed

Implementation of a Multidisciplinary Eye Clinic within a Cancer Center for Patients at Risk of Ocular Graft versus Host Disease.
Reshmi Talwar, Jihyun J Min, Desai Oula, Alex Wolfson, Katie Lowe
Ophthalmology Science. 2026-09-01
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphoma.
Nancy M Hardy, Jean A Yared, Tim Luetkens, Haroon Ahmad, Rediet Mulatu
Haematologica. 2026-04-01
Successful treatment of refractory cold agglutinin syndrome using fixed-duration daratumumab, bortezomib and dexamethasone with a sutimlimab bridge.
Brad Rybinski, Miranda James, Nancy Hardy, Rima Koka, Aaron P Rapoport
Haematologica. 2025-09-01

Abstracts/Posters

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...
Nancy M. Hardy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier
Nancy M. Hardy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019